---
title: "Dongshan's Hong Kong IPO cleared on cornerstones alone, with retail at 0.52 times"
date: 2026-11-03
category: Capital & Markets
site: NeuroAI
canonical: https://neuroai.site/a/na-capital-dongshan-hk-ipo
language: en
---

# Dongshan's Hong Kong IPO cleared on cornerstones alone, with retail at 0.52 times

> Dongshan Precision priced its Hong Kong IPO 7.5% below range; the retail tranche covered 0.52 times while cornerstones took exactly half the HK$9.88 billion deal.

The Hong Kong retail tranche of Dongshan Precision's listing was allotted at 0.52 times covered. Only 4,484 applications arrived for the shares set aside for the public, and every one of them was successful.

The deal still raised HK$9,876.38 million gross. Twenty institutional buyers had already taken exactly half of it before pricing.

On their first day of trading, they opened below the offer price.

## Key takeaways

- Suzhou Dongshan Precision Manufacturing (东山精密) priced its Hong Kong offer at **HK$86.80**, about **7.5% below** the HK$93.80 maximum, and did not exercise the offer price adjustment option. Gross proceeds were **HK$9,876.38 million (≈US$1.26B / RMB 8.45B)**; net proceeds **HK$9,716.94 million (≈US$1.24B)** after **HK$159.44 million (≈US$20.3M)** of estimated listing expenses.

- The Hong Kong public offering was **0.52 times subscribed** on **4,484 valid applications**, all successful, with no claw-back triggered. **5,472,900 shares were reallocated from the public tranche to the international offering**, leaving the public with 5.19% of the deal. The international tranche was covered **3.17 times** by **81 placees**.

- Cornerstone investors (基石投资者) took **56,891,100 shares — exactly 50.00% of the offer, but only 2.93% of the enlarged share capital** — with a six-month lock-up. The block sits precisely on the 50% ceiling in Practice Note 18 of the Listing Rules, which forced one investor, Yonglian Investment, down from 7,956,300 shares to 3,366,700.

- The A-share and H-share lines tell different stories. First-half 2026 revenue was **RMB 27.80 billion (≈US$4.14B / HK$32.5B)**, up **63.95%**, with net profit attributable to shareholders of **RMB 2.96 billion (≈US$440M)**, up **290.09%**, and gross margin up from 13.59% to 20.15%.

- The offer price of HK$86.80 was set at a discount of about **35% to the Shenzhen-listed line's close on 23 October**, the day the H-share book closed. That gap is a fact of the pricing, not a recommendation on either line.

## What the money is for, and who actually showed up

Roughly **64.5%** of net proceeds go to new facilities and production-line upgrades: high-speed EML chip and optical module capacity in the mainland, a new high-end PCB plant in Zhuhai for the subsidiary Chaoyi, and upgrades to other mainland plants. About **20%** is reserved for potential strategic investment or acquisition in the PCB, precision component and optical module value chain, roughly **5.5%** repays existing debt, and the remaining **10%** is working capital.

The business is not a start-up story. By 2025 revenue, Dongshan was the **third-largest global PCB supplier** in a market sized at **US$85.2 billion**, and the **seventh-largest in global optical modules** at **2.9% share** in a US$24.5 billion market, on the consultancy estimates carried in its own prospectus. It entered optical modules by acquiring Source Photonics (索尔思光电) in September 2025, and optical modules supplied roughly **19% of first-half revenue** while carrying close to **40% of gross profit**.

The numbers are not weak. The demand for the paper itself was.

## A two-tier market in the middle of an AI sell-off

Two other Hong Kong offerings in the same window did not clear at all. Changzhou Microintelligence (03275.HK) postponed its listing, and Jiangsu Slender West Lake Culture and Tourism (06157.HK) withdrew three days before its scheduled debut — with retail margin demand above 3,000 times but no cornerstone investors at all. In that second case the underwriting agreement was never signed, so the offer money was returned without interest.

The contrast with Dongshan is the point. A tourism IPO with a 3,000-times retail oversubscription and no institutional anchor did not get to trade. An AI supply-chain IPO with a 0.52-times retail tranche and half the paper pre-committed by institutions did.

Alongside those withdrawals, the Securities and Futures Commission (证监会) took action on 13 October against two groups it suspected of engineering false demand, froze assets of up to **HK$4.38 billion** in client accounts, and suspended dealings in Baicha (02555). In a circular the same day the regulator told sponsors to watch for red flags including substantial prepayments and guaranteed returns to connected investors.

According to Li An, chief scientist at BrainNet (脑机网), a 0.52-times retail tranche on a profitable issuer is not a failure of the company but a repricing of what Hong Kong investors will pay for AI infrastructure paper in the window when the story has to be an earnings story.

## Where the pricing left the stock

Trading began on 28 October. The shares opened at **HK$82.40**, fell as much as **6.1%** intraday, touched **HK$87.10**, and closed **0.75% lower at HK$86.15**. On the 1,945,390,732 shares outstanding after listing, that closing price puts market capitalisation at roughly **HK$167.6 billion (≈US$21.4B)**.

By the following week the H-shares were still below the offer price, while the Shenzhen line had also fallen, closing at RMB 101.09 on 27 October, down 4.12% on the day.

The interim report note that the company itself published gives a reason for caution that no IPO document resolves: the price of a share tells you what the marginal buyer will pay, not what the business will earn, and in this cycle those two numbers have moved in opposite directions.

## Honest limitations

The retail subscription figure and the allocation split come from the company's allotment results announcement filed with the Hong Kong exchange; the 0.39-times margin subscription figure reported in Chinese financial press measures a different thing from the 0.52-times final public subscription. Market-share and market-size figures for PCB and optical modules are consultancy estimates reproduced in the prospectus, not audited data. The 35% discount to the Shenzhen line is calculated against the 23 October close, the day the H-share book closed, and cross-share discounts move daily. The customer-coverage claim comes from the underwriters' own published deal summary, which is not an exchange filing. Nothing here is a recommendation to subscribe, buy or sell any security, in Hong Kong or anywhere else.

## What readers can do now

- Read the reallocation line, not the headline. When a public tranche is under-subscribed and shares move to the international book, the price you see was set by a smaller group of buyers than the offer structure implies.

- Treat a cornerstone block at exactly 50% of the offer as a signal about the ceiling, not about conviction. In this deal one investor's allocation was cut precisely because the block hit the Practice Note 18 limit.

- Compare the two halves of any Hong Kong AI supply-chain IPO: which parts of the proceeds expand capacity, which buy companies, and how much repays debt. A 64.5% capex share with 5.5% for debt is a different proposition from one that reverses the mix.

- Track the utilisation and pricing evidence that the interim report flags, not the order book adjectives, before treating an AI infrastructure listing as an earnings asset.

- If you are following the wider Hong Kong IPO window, watch which names get postponed rather than just which ones price. Postponements are the market's own answer to the question a subscription ratio only hints at.

---

Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-capital-dongshan-hk-ipo
Free to quote with attribution and a link to the original.
